Effect of single-pill versus free equivalent combinations on persistence and major adverse cardiovascular events in hypertension: a real-world analysis
This study further supports the beneficial effects of the use of SPC on 60-month persistence and MACEs in hypertension.
Authors
- Gábor G. Kovács
- Mohamed Abdel-Moneim
- Gábor Simonyi (ORCID: https://orcid.org/0000-0002-5205-3820)
- György Rokszin (ORCID: https://orcid.org/0009-0002-0568-001X)
- Zsolt Abonyi‐Tóth (ORCID: https://orcid.org/0000-0002-5585-3313)
- Michel Burnier (ORCID: https://orcid.org/0000-0003-1283-8487)
- Krzysztof Narkiewicz (ORCID: https://orcid.org/0000-0001-5949-5018)
- Praveen Kumar Potukuchi
- Csaba Farsang
Institutions
- Target (United States) (US)
- University of Sharjah (AE)
- Sanofi (United States) (US)
- University of Veterinary Medicine (HU)
- Sanofi (Mexico) (MX)
- Syreon Research Institute (Hungary) (HU)
- Gdańsk Medical University (PL)
- University of Lausanne (CH)
Publication Details
- Journal
- Journal of Hypertension
- Published
- 2024-12-06
- DOI
- https://doi.org/10.1097/hjh.0000000000003916
- Citations
- 8
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 3.22
Funders
- Sanofi